These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26702564)

  • 1. Bacteriophage therapy: Fast-forward to the past lessons identified from the advanced therapy regulation.
    Verbeken G; Huys I; Ceulemans C; Jennes S; De Vos D; Pirnay JP
    Burns; 2016 Feb; 42(1):11-12. PubMed ID: 26702564
    [No Abstract]   [Full Text] [Related]  

  • 2. Access to bacteriophage therapy: discouraging experiences from the human cell and tissue legal framework.
    Verbeken G; Huys I; De Vos D; De Coninck A; Roseeuw D; Kets E; Vanderkelen A; Draye JP; Rose T; Jennes S; Ceulemans C; Pirnay JP
    FEMS Microbiol Lett; 2016 Feb; 363(4):. PubMed ID: 26678555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cultured autologous keratinocyte sheets: use on large area burns.
    Shelton J
    J Wound Care; 2001 Sep; 10(8):307-9. PubMed ID: 12964333
    [No Abstract]   [Full Text] [Related]  

  • 4. Cultured allogenic keratinocytes for extensive burns: a retrospective study over 15 years.
    Auxenfans C; Shipkov H; Bach C; Catherine Z; Lacroix P; Bertin-Maghit M; Damour O; Braye F
    Burns; 2014 Feb; 40(1):82-8. PubMed ID: 23764150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation on the therapeutical efficiency of some adapted bacteriophages in experimental infection with Pseudomonas aeruginosa.
    Meitert E; Petrovici M; Sima F; Costache G; Savulian C
    Arch Roum Pathol Exp Microbiol; 1987; 46(1):17-26. PubMed ID: 3124795
    [No Abstract]   [Full Text] [Related]  

  • 6. [Production of autologous keratinocytes for therapeutic purposes within a pharmaceutical company].
    Guillot FL
    J Soc Biol; 2001; 195(1):75-7. PubMed ID: 11530505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Covering wounds with cultured keratinocytes.
    Woodley DT
    JAMA; 1989 Oct; 262(15):2140-1. PubMed ID: 2795787
    [No Abstract]   [Full Text] [Related]  

  • 8. [Keratinocyte culture and transplantation in burns].
    Mühlbauer W; Henckel von Donnersmarck G; Hoefter E; Hartinger A
    Chirurg; 1995 Apr; 66(4):271-6. PubMed ID: 7634934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriophage Production in Compliance with Regulatory Requirements.
    Pirnay JP; Merabishvili M; Van Raemdonck H; De Vos D; Verbeken G
    Methods Mol Biol; 2018; 1693():233-252. PubMed ID: 29119444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory watch: European regulatory experience with advanced therapy medicinal products.
    Barkholt L; Voltz-Girolt C; Raine J; Salmonson T; Schüssler-Lenz M
    Nat Rev Drug Discov; 2019 Jan; 18(1):8-9. PubMed ID: 30498203
    [No Abstract]   [Full Text] [Related]  

  • 11. [Present and future of cell therapy in burns].
    Bargues L; Prat M; Leclerc T; Bey E; Lataillade JJ
    Pathol Biol (Paris); 2011 Jun; 59(3):e49-56. PubMed ID: 20167439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteriophages in the experimental treatment of Pseudomonas aeruginosa infections in mice.
    Saussereau E; Debarbieux L
    Adv Virus Res; 2012; 83():123-41. PubMed ID: 22748810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing the European regulatory framework for sustainable bacteriophage therapy in human medicine.
    Verbeken G; Pirnay JP; De Vos D; Jennes S; Zizi M; Lavigne R; Casteels M; Huys I
    Arch Immunol Ther Exp (Warsz); 2012 Jun; 60(3):161-72. PubMed ID: 22527355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sprayed cultured autologous keratinocytes used alone or in combination with meshed autografts to accelerate wound closure in difficult-to-heal burns patients.
    James SE; Booth S; Dheansa B; Mann DJ; Reid MJ; Shevchenko RV; Gilbert PM
    Burns; 2010 May; 36(3):e10-20. PubMed ID: 19303712
    [No Abstract]   [Full Text] [Related]  

  • 15. Informed consent and living human cells.
    Maloney DM
    Hum Res Rep; 2002 Jul; 17(7):3. PubMed ID: 12731490
    [No Abstract]   [Full Text] [Related]  

  • 16. [Important aspects of virus safety of advanced therapy medicinal products].
    Blümel J; Stühler A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jan; 53(1):38-44. PubMed ID: 19937308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The autotransplantation of keratinocytes grown outside the body to treat extensive burns].
    Malakhov SF; Terskikh VV; Bautin EA; Vasil'ev AV; Paramonov BA
    Vestn Khir Im I I Grek; 1993; 150(3-4):59-62. PubMed ID: 8379083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cultured autologous keratinocytes in the treatment of large and deep burns: a retrospective study over 15 years.
    Auxenfans C; Menet V; Catherine Z; Shipkov H; Lacroix P; Bertin-Maghit M; Damour O; Braye F
    Burns; 2015 Feb; 41(1):71-9. PubMed ID: 24996248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA oversight of cell therapy clinical trials.
    Au P; Hursh DA; Lim A; Moos MC; Oh SS; Schneider BS; Witten CM
    Sci Transl Med; 2012 Aug; 4(149):149fs31. PubMed ID: 22932219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of wound dressings on cultured primary keratinocytes.
    Esteban-Vives R; Young MT; Ziembicki J; Corcos A; Gerlach JC
    Burns; 2016 Feb; 42(1):81-90. PubMed ID: 26678326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.